| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Research and development | $6.8M-68.4% | $21.6M+135.3% | $9.2M |
| General and administrative | $6.9M-4.8% | $7.3M+7.8% | $6.7M |
| Total operating expenses | $13.7M-52.4% | $28.8M+81.3% | $15.9M |
| Loss from operations | -$13.7M+52.4% | -$28.8M-81.3% | -$15.9M |
| Gain from change in fair value of warrant liabilities | $225K-24.2% | $297K-89.9% | $3.0M |
| Interest income, net | $510K-44.6% | $920K+99.6% | $461K |
| Total other income | $735K-39.6% | $1.2M-64.4% | $3.4M |
| Loss before income taxes | -$13.0M+53.0% | -$27.6M-121.3% | -$12.5M |
| Provision for income taxes | $0 | $0 | $0 |
| Net loss | -$13.0M+53.0% | -$27.6M-121.3% | -$12.5M |
| Loss per share of common stock, basic (in dollars per share) | -$7.35+81.2% | -$39.13-1490.7% | -$2.46 |
| Loss per share of common stock, diluted (in dollars per share) | -$7.35+81.2% | -$39.13-1490.7% | -$2.46 |
| Weighted average shares of common stock, basic (in shares) | 1.77B+150.4% | 705.2M-86.1% | 5.07B |
| Weighted average shares of common stock, diluted (in shares) | 1.77B+150.4% | 705.2M-86.1% | 5.07B |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.